University of Washington spinout Monod Bio was awarded a $1.5 million grant from the Gates Foundation to develop a rapid urinary diagnostic test for tuberculosis suitable for low-resource settings. Utilizing their NovoBodies—algorithm-designed protein binders with enhanced specificity and sensitivity—the test aims to outperform current technologies through a novel lateral-flow assay format. The funding supports further development efforts building on $25 million in prior seed financing.